Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

More metabolite offerings
April 2020
SHARING OPTIONS:

SLOUGH, U.K.—A partnership is underway between Hypha Discovery Limited and Cypex Limited under which Hypha will scale up and purify metabolites produced by Cypex enzymes (available as Bactosomes). Hypha notes that it already offers a one-stop shop for scaling up metabolite production, and adds that this partnership allows the company to offer more options, including additional xenobiotic-metabolizing enzymes developed by Cypex. The latter's portfolio boasts recombinant enzymes and a patented technology that allows for the expression of mammalian drug-metabolizing enzymes in bacteria. With this partnership, the companies can offer access to metabolites derived from CYP, FMO, AOX, UGT, SULT, CES and MOA enzymes from clinically relevant species, as well as humans.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.